Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.760 | 8.760 | 0.000 |
Stocks | 92.000 | 92.050 | 0.050 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.594 | 18.836 |
Price to Book | 3.462 | 2.977 |
Price to Sales | 4.427 | 2.621 |
Price to Cash Flow | 12.529 | 10.596 |
Dividend Yield | 0.850 | 2.292 |
5 Years Earnings Growth | 7.059 | 11.956 |
Number of long holdings: 236
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 7.61 | 476.18 | +0.78% | |
Amgen | US0311621009 | 7.09 | 315.32 | +0.52% | |
Regeneron Pharma | US75886F1075 | 7.08 | 1,050.91 | +0.00% | |
Gilead | US3755581036 | 7.02 | 68.67 | -0.23% | |
Moderna | US60770K1079 | 3.50 | 121.79 | +0.50% | |
Biogen | US09062X1037 | 3.47 | 233.10 | +1.91% | |
AstraZeneca ADR | US0463531089 | 3.46 | 78.67 | +0.62% | |
ProShares Ultra Nasdaq Biotechnology | US74347R2141 | 3.11 | 59.79 | +0.30% | |
Alnylam | US02043Q1076 | 2.22 | 243.70 | -1.34% | |
Illumina | US4523271090 | 2.04 | 105.82 | -0.61% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDII USD | 1.61B | 9.60 | 9.35 | - | ||
GF Global Selction Eq QDII USD | 1.13B | 14.70 | -1.19 | - | ||
GF American Estate Index QDII USD | 19.39M | -3.54 | -1.61 | 3.54 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review